Abstract
The characterization of mutations in Japanese patients with lipidosis, particularly in metachromatic leukodystrophy (MLD) and Gaucher disease has been studied in detail. Metachromatic leukodystrophy is characterized by an accumulation of sulfatide in nervous tissues and kidney due to a deficiency of arylsulfatase A (ASA). We analyzed the presence of three known mutant arylsulfatase A alleles in Japanese patients with MLD. Among 10 patients of Japanese patients with MLD, we found that allele 445A mutation has moderately high incidence and also homozygosity of this mutation results in the late infantile form. Allele 2381T was not found in Japanese patients. Furthermore, we found novel mutation which is G- to A mutation at the 1070 nucleotide of the ASA gene (designated 1070 A) in Japanese patients with juvenile onset. This mutation results in a amino acid substitution of Gly245 by Arg and found in heterozygote form. Our studies of molecular analysis in 10 Japanese patients with MLD indicate that Japanese MLD patients have unique characteristics of ASA mutations compared with those of Caucasian patients. On the other hand, Gaucher disease is the most prevalent sphingolipidosis, characterized by an accumulation of glucocerebroside in macrophage derived cells due to a deficiency of lysosomal hydrolase glucocerebrosidase. To study the molecular basis of Gaucher disease in Japanese patients, we analyzed the presence of the two known mutations (6433C and 3548A) in the glucocerebrosidase gene of 15 patients with Gaucher disease. We found that the 6433C and 3548A mutations occur in all subtypes of Japanese patients with Gaucher disease. Most frequent mutations among them was the 6433C mutation, 40% of 30 chromosomes, whereas the novel mutation of the 3548A found in Japanese patients with neuronopathic Gaucher disease was found in 20% (6 out of 30 chromosomes). The characteristics of these mutations in Japanese patients with Gaucher disease is different from those of Caucasian populations reported previously. (Mol Cell Biochem 119:179-184, 1993)
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mehl E, Jatzkewitz H: Evidence for the genetic block in meta-chromatic leukodystrophy. Biochem Biophys Res Commun 19: 407–411, 1965
Stein C, Gieselman V, Kreysing J, Schmidt B, Pohlmann R, Waheed A, Meyer HE, O’Brien JS, Von Figura K: Cloning and expression of human arylsulfatase A. J Biol Chem 264: 1252–1259, 1989
Kreysing J, Von Figura K, Gieselmann V: Structure of the arylsulfatase A gene. Europ J Biochem 191: 627–631, 1990
Polten A, Fluharty AL, Fluharty CB, Kappler J, Von Figura K, Gieselmann V: Molecular basis of different forms of metachro-matic leukodystrophy. N Engl J Med 324:18–22, 1991
Bohne W, Von Figura K, Gieselamm V: An 11 bp deletion in the arylsulfatase A gene of a patient with late infantile metachromatic leukodystrophy. Hum Genet 87:155–158, 1991
Gieselmann V, Fluharty AL, Tonnesen T, Von Figura K: Mutations in the arylsulfatase A pseudodeficiency allele causing meta-chromatic leukodystrophy. Am J Hum Genet 49: 407–413, 1991
Fluharty AL, Fluharty CB, Bohne W, Von Figura K, Gieselmann V: Two new arylsulfatase A (ARSA) mutations in a juvenile metachromatic leukodystrophy (MLD) patient. Am J Hum Genet 49: 1340–1350, 1991
Kappler J, Von Figura K, Gieselmann V: Late onset meta-chromatic leukodystrophy: Molecular pathology in two siblings. Ann Neurol 31: 256–261, 1992
Brady RO, Kanfer JN, Shapiro D: Metabolism of glucocerebro-sidase. II. Evidence of an enzymatically deficiency in Gaucher’s disease. Biochem Biophys Res Commun 18: 221–225, 1965
Sorge J, West C, Westwood B, Beutler E: cDNA cloning of human glucocerebrosidase gene. Proc Natl Acad Sci USA 82: 7289–7293, 1985
Tsuji S, Choudary PV, Martin BM, Winfield S, Barranger JA, Ginns EI: Nucleotide sequence of cDNA containing the complete coding sequence for human lysosomal glucocerebrosidase. J Biol Chem 261: 50–53, 1985
Tsuji S, Choudary PV, Martin BM, Major JA, Barranger JA, Ginns EI: A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher disease. N Engl J Med 316: 570–575, 1987
Theophilus BDM, Latham T, Grabowski GA, Smith FI: Gaucher disease: Molecular heterogeneity and phenotype-genotype correlation. Am J Hum Genet 45: 212–225, 1989
Beutler E, Gilbart T, Kuhl W, Sorge J, West C: Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state. Proc Natl Acad Sci, USA 88: 10544–10547, 1991
Latham T, Grabowski GA, Theophilus BDM, Smith FI: Complex allele of the acid beta-glucosidase gene in Gaucher disease. Am J Hum Genet 47: 79–86, 1990
Kawame H, Eto Y: A new mutation glucocerebrosidase-gene missense mutation responsible for neuronopathic Gaucher disease in Japanese patients. Am J Hum Genet 49: 1378–1380, 1991
Maniatis T, Fritsch EF, Sambrook J: Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1982
Hasegawa Y, Kawame H, Eto Y: Mutations in arylsulfatase A (ASA) gene of Japanese patients with metachromatic leukodystrophy (MLD). DNA and Biology, in press, 1992
Kawame H, Maekawa K, Eto Y: Molecular screening of Japanese patients with Gaucher disease: Phenotypic variabilities in the same genotypes. Human Mutation, in press, 1992
Kondo R, Wakamatsu N, Yoshino H, Fukuhara N, Miyatake T, Tsuji S: Identification of a mutation in the arylsulfatase A gene of a patient with adult-type metachromatic leukodystrophy. Am J Hum Genet 48: 971–978, 1991
Sidransky E, Tsuji S, Martin BM, Stubblefield B, Ginns El: DNA mutation analysis of Gaucher disease. Am J Med Genet 42: 331–336, 1992
Masuno M, Tomatsu S, Sukegawa K, Orii T: Non-existence of a tight association between a 444 Leucine to proline mutation and phenotypes of Gaucher disease: High frequency of a Nci I polymorphism in the non-neuronopathic form. Hum Genet 84: 203–206, 1990
Kawame H, Hasegawa Y, Maekawa K, Eto Y: Rapid identification of mutations in the glucocerebrosidase gene of Gaucher disease patients by analysis of single strand conformation polymorphism (SSCP) Hum Genet, in press, 1992
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Eto, Y., Kawame, H., Hasegawa, Y., Ohashi, T.A., Ida, H., Tokoro, T. (1993). Molecular Characteristics in Japanese Patients with Lipidosis: Novel Mutations in Metachromatic Leukodystrophy and Gaucher Disease. In: Yazaki, Y., Mochizuki, S. (eds) Cellular Function and Metabolism. Developments in Molecular and Cellular Biochemistry, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3078-7_24
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3078-7_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6344-6
Online ISBN: 978-1-4615-3078-7
eBook Packages: Springer Book Archive